Pharmacology, Internal medicine, Endocrinology, Immunology and Endocannabinoid system are his primary areas of study. Pal Pacher has researched Pharmacology in several fields, including Peroxynitrite, Oxidative stress, Biochemistry, Nitric oxide and Reperfusion injury. His work on Vasodilation, Fatty acid synthase and Appetite as part of general Internal medicine study is frequently connected to TRPV1, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His study in Endocrinology is interdisciplinary in nature, drawing from both Diabetic cardiomyopathy and Mitochondrion. In his study, Cell biology and Cytosol is inextricably linked to Receptor, which falls within the broad field of Immunology. His work deals with themes such as Anandamide, Cannabinoid Receptor Modulators, Cannabinoid receptor, Cannabinoid and Neuroscience, which intersect with Endocannabinoid system.
Pal Pacher focuses on Internal medicine, Endocrinology, Pharmacology, Inflammation and Immunology. The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Cardiology. His Endocrinology research incorporates themes from Poly ADP ribose polymerase and PARP inhibitor.
His Pharmacology research includes elements of Peroxynitrite, Oxidative stress, Biochemistry, Cannabinoid and Reperfusion injury. His biological study deals with issues like Nitric oxide, which deal with fields such as Peroxynitrous acid. His Receptor research incorporates elements of Adenosine and Cell biology.
His scientific interests lie mostly in Internal medicine, Endocrinology, Inflammation, Receptor and Pharmacology. His Internal medicine research is multidisciplinary, relying on both Diabetes mellitus, Oncology and Cardiology. His Endocrinology study combines topics from a wide range of disciplines, such as Endocannabinoid system and Fatty liver.
His studies in Inflammation integrate themes in fields like Fibrosis, Oxidative stress and Purinergic receptor. His Receptor research integrates issues from Extracellular, Cell biology and Sepsis. His study looks at the relationship between Pharmacology and topics such as Cardiotoxicity, which overlap with Clinical trial and Drug.
Pal Pacher mainly focuses on Pharmacology, Internal medicine, Immunology, Inflammation and Endocrinology. His research in Pharmacology intersects with topics in PARP inhibitor, Cardiotoxicity, Mitochondrion and Olaparib. His studies deal with areas such as Oncology and Drug as well as Internal medicine.
The Immunology study combines topics in areas such as Biomarker, Cancer research, Alcoholic liver disease and Liver injury. His Inflammation research is multidisciplinary, incorporating elements of Receptor and Immune system. In his research, Endocannabinoid system, Pancreatic islets, Nephropathy and Pathogenesis is intimately related to Fibrosis, which falls under the overarching field of Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nitric Oxide and Peroxynitrite in Health and Disease
Pál Pacher;Joseph S. Beckman;Lucas Liaudet.
Physiological Reviews (2007)
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pál Pacher;Sándor Bátkai;George Kunos.
Pharmacological Reviews (2006)
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
Pál Pacher;Alex Nivorozhkin;Csaba Szabó;Csaba Szabó.
Pharmacological Reviews (2006)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
Douglas Osei-Hyiaman;Michael DePetrillo;Pál Pacher;Jie Liu.
Journal of Clinical Investigation (2005)
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
György Haskó;Joel Linden;Bruce Cronstein;Pál Pacher.
Nature Reviews Drug Discovery (2006)
CD39 and CD73 in immunity and inflammation
Luca Antonioli;Pál Pacher;E. Sylvester Vizi;E. Sylvester Vizi;György Haskó.
Trends in Molecular Medicine (2013)
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
Oleg V. Evgenov;Pál Pacher;Peter M. Schmidt;György Haskó.
Nature Reviews Drug Discovery (2006)
Activation of the peripheral endocannabinoid system in human obesity.
Stefan Engeli;Jana Böhnke;Mareike Feldpausch;Kerstin Gorzelniak.
Diabetes (2005)
Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats
Pál Pacher;Takahiro Nagayama;Partha Mukhopadhyay;Sándor Bátkai.
Nature Protocols (2008)
Immunity, inflammation and cancer: a leading role for adenosine
Luca Antonioli;Corrado Blandizzi;Pál Pacher;György Haskó;György Haskó.
Nature Reviews Cancer (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Columbia University
University of Fribourg
University of Lausanne
National Institutes of Health
University of Oklahoma Health Sciences Center
National Institutes of Health
University of Oklahoma Health Sciences Center
University of Debrecen
Indiana University
Rutgers, The State University of New Jersey
Hebrew University of Jerusalem
University of Tübingen
The Ohio State University
Korea University
WaveOne, Inc.
University of Ljubljana
Philipp University of Marburg
Ludwig-Maximilians-Universität München
Sichuan University
University of Queensland
Karolinska Institute
University of Victoria
University of Hawaii at Manoa
The Ohio State University
Karolinska University Hospital
The University of Texas at Austin